Literature DB >> 32396181

Association Between Initiation of Pulmonary Rehabilitation After Hospitalization for COPD and 1-Year Survival Among Medicare Beneficiaries.

Peter K Lindenauer1,2,3, Mihaela S Stefan1,2, Penelope S Pekow1,4, Kathleen M Mazor5, Aruna Priya1,4, Kerry A Spitzer1, Tara C Lagu1,2, Quinn R Pack1,2,6, Victor M Pinto-Plata2,7, Richard ZuWallack8.   

Abstract

Importance: Meta-analyses have suggested that initiating pulmonary rehabilitation after an exacerbation of chronic obstructive pulmonary disease (COPD) was associated with improved survival, although the number of patients studied was small and heterogeneity was high. Current guidelines recommend that patients enroll in pulmonary rehabilitation after hospital discharge. Objective: To determine the association between the initiation of pulmonary rehabilitation within 90 days of hospital discharge and 1-year survival. Design, Setting, and Patients: This retrospective, inception cohort study used claims data from fee-for-service Medicare beneficiaries hospitalized for COPD in 2014, at 4446 acute care hospitals in the US. The final date of follow-up was December 31, 2015. Exposures: Initiation of pulmonary rehabilitation within 90 days of hospital discharge. Main Outcomes and Measures: The primary outcome was all-cause mortality at 1 year. Time from discharge to death was modeled using Cox regression with time-varying exposure to pulmonary rehabilitation, adjusting for mortality and for unbalanced characteristics and propensity to initiate pulmonary rehabilitation. Additional analyses evaluated the association between timing of pulmonary rehabilitation and mortality and between number of sessions completed and mortality.
Results: Of 197 376 patients (mean age, 76.9 years; 115 690 [58.6%] women), 2721 (1.5%) initiated pulmonary rehabilitation within 90 days of discharge. A total of 38 302 (19.4%) died within 1 year of discharge, including 7.3% of patients who initiated pulmonary rehabilitation within 90 days and 19.6% of patients who initiated pulmonary rehabilitation after 90 days or not at all. Initiation within 90 days was significantly associated with lower risk of death over 1 year (absolute risk difference [ARD], -6.7% [95% CI, -7.9% to -5.6%]; hazard ratio [HR], 0.63 [95% CI, 0.57 to 0.69]; P < .001). Initiation of pulmonary rehabilitation was significantly associated with lower mortality across start dates ranging from 30 days or less (ARD, -4.6% [95% CI, -5.9% to -3.2%]; HR, 0.74 [95% CI, 0.67 to 0.82]; P < .001) to 61 to 90 days after discharge (ARD, -11.1% [95% CI, -13.2% to -8.4%]; HR, 0.40 [95% CI, 0.30 to 0.54]; P < .001). Every 3 additional sessions was significantly associated with lower risk of death (HR, 0.91 [95% CI, 0.85 to 0.98]; P = .01). Conclusions and Relevance: Among fee-for-service Medicare beneficiaries hospitalized for COPD, initiation of pulmonary rehabilitation within 3 months of discharge was significantly associated with lower risk of mortality at 1 year. These findings support current guideline recommendations for pulmonary rehabilitation after hospitalization for COPD, although the potential for residual confounding exists and further research is needed.

Entities:  

Mesh:

Year:  2020        PMID: 32396181      PMCID: PMC7218499          DOI: 10.1001/jama.2020.4437

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   157.335


  33 in total

1.  Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect.

Authors:  Tobias Kurth; Alexander M Walker; Robert J Glynn; K Arnold Chan; J Michael Gaziano; Klaus Berger; James M Robins
Journal:  Am J Epidemiol       Date:  2005-12-21       Impact factor: 4.897

2.  Using inverse probability-weighted estimators in comparative effectiveness analyses with observational databases.

Authors:  Lesley H Curtis; Bradley G Hammill; Eric L Eisenstein; Judith M Kramer; Kevin J Anstrom
Journal:  Med Care       Date:  2007-10       Impact factor: 2.983

3.  Comorbidity measures for use with administrative data.

Authors:  A Elixhauser; C Steiner; D R Harris; R M Coffey
Journal:  Med Care       Date:  1998-01       Impact factor: 2.983

Review 4.  Evidence for Health Decision Making - Beyond Randomized, Controlled Trials.

Authors:  Thomas R Frieden
Journal:  N Engl J Med       Date:  2017-08-03       Impact factor: 91.245

5.  Management of COPD exacerbations: a European Respiratory Society/American Thoracic Society guideline.

Authors:  Jadwiga A Wedzicha; Marc Miravitlles; John R Hurst; Peter M A Calverley; Richard K Albert; Antonio Anzueto; Gerard J Criner; Alberto Papi; Klaus F Rabe; David Rigau; Pawel Sliwinski; Thomy Tonia; Jørgen Vestbo; Kevin C Wilson; Jerry A Krishnan
Journal:  Eur Respir J       Date:  2017-03-15       Impact factor: 16.671

6.  Hospital discharges, readmissions, and ED visits for COPD or bronchiectasis among US adults: findings from the nationwide inpatient sample 2001-2012 and Nationwide Emergency Department Sample 2006-2011.

Authors:  Earl S Ford
Journal:  Chest       Date:  2015-04       Impact factor: 9.410

Review 7.  Pulmonary rehabilitation: WHAT WE KNOW AND WHAT WE NEED TO KNOW.

Authors:  Linda Nici; Jonathan Raskin; Carolyn L Rochester; Jean C Bourbeau; Brian W Carlin; Richard Casaburi; Bartolome R Celli; Claudia Cote; Rebecca H Crouch; Luis F Diez-Morales; Claudio F Donner; Bonnie F Fahy; Chris Garvey; Roger Goldstein; Alison Lane-Reticker; Suzanne C Lareau; Barry Make; François Maltais; James McCormick; Michael D L Morgan; Andrew Ries; Thierry Troosters; Richard ZuWallack
Journal:  J Cardiopulm Rehabil Prev       Date:  2009 May-Jun       Impact factor: 2.081

Review 8.  Rehabilitation following hospitalization in patients with COPD: can it reduce readmissions?

Authors:  Matthew Maddocks; Samantha S C Kon; Sally J Singh; William D-C Man
Journal:  Respirology       Date:  2014-12-22       Impact factor: 6.424

9.  Risk Trajectories of Readmission and Death in the First Year after Hospitalization for Chronic Obstructive Pulmonary Disease.

Authors:  Peter K Lindenauer; Kumar Dharmarajan; Li Qin; Zhenqiu Lin; Andrea S Gershon; Harlan M Krumholz
Journal:  Am J Respir Crit Care Med       Date:  2018-04-15       Impact factor: 30.528

10.  Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples.

Authors:  Peter C Austin
Journal:  Stat Med       Date:  2009-11-10       Impact factor: 2.373

View more
  37 in total

Review 1.  Application of pulmonary rehabilitation in patients with pulmonary embolism (Review).

Authors:  Aiping Yu; Weiping Ding; Wanmi Lin; Juan Cai; Weina Huang
Journal:  Exp Ther Med       Date:  2021-12-01       Impact factor: 2.447

2.  Pulmonary Rehabilitation and Readmission Rates for Medicare Beneficiaries with Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Laura C Myers; Mohammad Kamal Faridi; Kohei Hasegawa; Carlos A Camargo
Journal:  Chronic Obstr Pulm Dis       Date:  2021-10-28

Review 3.  Advances in Chronic Obstructive Pulmonary Disease.

Authors:  Michael C Ferrera; Wassim W Labaki; MeiLan K Han
Journal:  Annu Rev Med       Date:  2021-01-27       Impact factor: 13.739

Review 4.  Management of Refractory Breathlessness: a Review for General Internists.

Authors:  Annie Massart; Daniel P Hunt
Journal:  J Gen Intern Med       Date:  2021-01-19       Impact factor: 5.128

5.  Respiratory exacerbations are associated with muscle loss in current and former smokers.

Authors:  Stefanie Elizabeth Mason; Rafael Moreta-Martinez; Wassim W Labaki; Matthew Strand; David Baraghoshi; Elizabeth A Regan; Jessica Bon; Ruben San Jose Estepar; Richard Casaburi; Merry-Lynn N McDonald; Harry Rossiter; Barry J Make; Mark T Dransfield; MeiLan K Han; Kendra A Young; Greg Kinney; John E Hokanson; Raul San Jose Estepar; George R Washko
Journal:  Thorax       Date:  2021-02-11       Impact factor: 9.139

6.  [Rehabilitation in pneumology].

Authors:  Daniela Leitl; Inga Jarosch; Rainer Glöckl; Tessa Schneeberger; Andreas Rembert Koczulla
Journal:  Pneumologe (Berl)       Date:  2021-05-07

Review 7.  [Referral to pulmonary rehabilitation and its options for chronic lung disease patients].

Authors:  Inga Jarosch; Tessa Schneeberger; Rainer Glöckl; Daniela Leitl; Andreas Rembert Koczulla
Journal:  MMW Fortschr Med       Date:  2021-05

8.  Access to, use, knowledge, and preferences for information technology and technical equipment among people with chronic obstructive pulmonary disease (COPD) in Sweden. A cross-sectional survey study.

Authors:  Pernilla Sönnerfors; Kirsti Skavberg Roaldsen; Agneta Ståhle; Karin Wadell; Alexandra Halvarsson
Journal:  BMC Med Inform Decis Mak       Date:  2021-06-10       Impact factor: 2.796

Review 9.  Post-COVID-19 Syndrome and the Potential Benefits of Exercise.

Authors:  Amaya Jimeno-Almazán; Jesús G Pallarés; Ángel Buendía-Romero; Alejandro Martínez-Cava; Francisco Franco-López; Bernardino J Sánchez-Alcaraz Martínez; Enrique Bernal-Morel; Javier Courel-Ibáñez
Journal:  Int J Environ Res Public Health       Date:  2021-05-17       Impact factor: 3.390

10.  Post-infectious and post-acute sequelae of critically ill adults with COVID-19.

Authors:  Halah Ibrahim; Syed Athar; Thana Harhara; Shahad Abasaeed Elhag; Salma MElnour; Hoor H Sukkar; Ashraf M Kamour
Journal:  PLoS One       Date:  2021-06-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.